FMR CORP 13D and 13G filings for Cytokinetics, Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Sale |
2024-12-31 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 11,146,954 9.400% |
-1,268,688 (-10.22%) |
Filing |
| 2024-11-12 09:55 am Sale |
2024-11-08 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 12,415,642 10.518% |
-592,141 (-4.55%) |
Filing |
| 2024-02-09 08:50 am Sale |
2024-02-08 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 13,007,783 13.265% |
-401,460 (-2.99%) |
Filing |
| 2023-02-09 09:59 am Purchase |
2023-02-09 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 13,409,243 14.162% |
819,408 (+6.51%) |
Filing |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 12,589,835 14.999% |
4,101,153 (+48.31%) |
Filing |
| 2021-07-12 12:07 pm Purchase |
2021-07-09 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 8,488,682 11.832% |
5,864,957 (+223.54%) |
Filing |